Published in
Elsevier, The Lancet Oncology, 9(13), p. 879-886
DOI: 10.1016/s1470-2045(12)70324-8
Links
Tools
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): An open-label, single-arm phase 2 trial
Journal article published in 2012 by
Anna Maria Di Giacomo,
Paolo A. Ascierto,
Lorenzo Pilla,
Mario Santinami,
Pier Francesco Ferrucci 
,
Diana Giannarelli ,
Antonella Marasco,
Licia Rivoltini,
Ester Simeone,
Stefania Vl Nicoletti,
Ester Fonsatti,
Diego Annesi,
Paola Queirolo ,
Alessandro Testori,
Ruggero Ridolfi
and other authors.
,
Diana Giannarelli ,
Antonella Marasco,
Licia Rivoltini,
Ester Simeone,
Stefania Vl Nicoletti,
Ester Fonsatti,
Diego Annesi,
Paola Queirolo ,
Alessandro Testori,
Ruggero Ridolfi
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 